Comedian Whitney Cummings headlines opening night MIAMI, Jan. 8, 2026 /PRNewswire/ — The World Jai-Alai League (WJAL) will kick off a fresh chapter for the sportComedian Whitney Cummings headlines opening night MIAMI, Jan. 8, 2026 /PRNewswire/ — The World Jai-Alai League (WJAL) will kick off a fresh chapter for the sport

JAM Arena Debuts as World Jai-Alai League Launches Ninth Season Feb. 13

Comedian Whitney Cummings headlines opening night

MIAMI, Jan. 8, 2026 /PRNewswire/ — The World Jai-Alai League (WJAL) will kick off a fresh chapter for the sport of professional jai-alai when it opens its ninth competitive Battle Court season Friday, Feb. 13, debuting play at the newly renovated and rebranded JAM Arena. Opening night begins at 7 p.m., followed by a headline performance from comedian Whitney Cummings at 10 p.m., setting the tone for a season that blends thrilling live action jai-alai with top-tier live entertainment.

The JAM Arena at the former Miami Jai-Alai facility at 3500 NW 37th Ave. in Miami – has undergone a multi-million-dollar renovation and rebranding project designed for a new era and a modern consumer. The 1,500-seat arena will feature state-of-the-art audience amenities including VIP courtside seating and family-friendly sports challenge activations designed to create an immersive fan experience.

“We’re ready to kick off a new chapter for the sport of jai-alai, a sport that is iconically Miami and introduce it to a new generation of fans,” said Scott Savin, chief operating officer of the World Jai-Alai League. “Pairing the world’s fastest ball sport with nationally-recognized entertainers like Whitney Cummings sets the tone for an updated sports and entertainment experience.”

Cummings, one of comedy’s most recognizable voices, headlines opening night as part of the Big Baby tour. A comedian, actor, writer, producer and director, she is the creator and star of NBC’s “Whitney” and the co-creator and co-writer of the Emmy-nominated CBS series “2 Broke Girls.” She is also the host of the popular podcast “Good For You” and released her sixth stand-up special, “Mouthy, in November 2023. Tickets for Whitney Cummings’ limited-engagement performance are available at www.jamarena.com.

The World Jai-Alai League’s Winter Battle Court season runs through May 8 and features high-intensity matchups, elite international athletes and a continued focus on community impact. Since 2022, the league has contributed more than $400,000 to South Florida nonprofits through its charitable partnerships.

Live jai-alai matches are open to the public on Fridays at the JAM Arena. Matches stream live on ESPN3 and are available for legal wagering in Florida via the Hard Rock Bet app, as well as nationally through DraftKings, FanDuel and ESPN Bet.

About World Jai-Alai League
The World Jai-Alai League (WJAL) is dedicated to revitalizing the world’s fastest ball sport by modernizing gameplay, capitalizing on the international sports wagering market, and delivering the sport through social media to a new generation of fans across the globe. The WJAL plays at the Magic City Fronton in Miami, located at 450 N.W. 37th Ave.

MEDIA CONTACT
Sandy Rodriguez
305-753-3787
407247@email4pr.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/jam-arena-debuts-as-world-jai-alai-league-launches-ninth-season-feb-13-302656491.html

SOURCE World Jai-Alai League

Market Opportunity
Tune.FM Logo
Tune.FM Price(JAM)
$0.000057
$0.000057$0.000057
+0.52%
USD
Tune.FM (JAM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26